Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03940300 · ClinicalTrials.gov registry record · NA
Farming for Life - Health Impact of Organic Vegetable Prescriptions for Adults Living With or at Risk of Type 2 Diabetes
A NA study, sponsored by Sansum Diabetes Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 303
- Enrollment target
NCT03940300 is a NA study that was terminated before completion, run by Sansum Diabetes Research Institute. The registered enrollment target is 303 participants.
The verdict
NCT03940300, a NA study, was terminated before completion, sponsored by Sansum Diabetes Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 303 participants
- Enrollment target
Study Summary
Farming for Life aims to determine the health impacts of providing weekly "prescriptions" of fresh organic vegetables to adults living with or at risk of type 2 diabetes. Over 4 years, up to 400 adults diagnosed with or at high risk of developing type 2 diabetes will be engaged for 3 months each, and receive weekly doses of locally-grown organic vegetable prescriptions. The end-points for comparison will be changes in blood pressure, weight, waist circumference, glycemic control \[defined as Time in Range (TIR) (70-140mg/dl)\] using continuous glucose monitoring (CGM), and HbA1c levels (a measure of long-term blood glucose level control) after 3 months compared to baseline measurements. Additional assessments will be made on the impact of the organic vegetable prescriptions on food security. At an optional Visit 13, offered 6 months after Visit 1, an additional health screening will be conducted. Prevalence and risk of type 2 diabetes in the US is disproportionately high among low income and minority groups and is exasperated by high levels of food insecurity. The investigators hypothesize that improving access to fresh organic vegetables will result in measurable health outcomes for adults with type 2 diabetes and those at risk of developing the condition. This represents a promising and potentially cost-effective strategy for improving diabetes outcomes at a population level, particularly among low income, minority populations with type 2 diabetes.
Interventions
- DIETARY_SUPPLEMENT Fresh organic vegetables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2019-01-28 |
| Est. Completion | 2022-05-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03940300
The ClinicalTrials.gov registry entry for NCT03940300 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fresh organic vegetables is the first listed.
NCT03940300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03940300 about?
NCT03940300 is a clinical study titled "Farming for Life - Health Impact of Organic Vegetable Prescriptions for Adults Living With or at Risk of Type 2 Diabetes". Farming for Life aims to determine the health impacts of providing weekly "prescriptions" of fresh organic vegetables to adults living with or at risk of type 2 diabetes. Over 4 years, up to 400 adults diagnosed with or at high risk of developing type 2 diabetes will be engaged for 3 months each, an...
What is the current status of trial NCT03940300?
This trial is currently terminated. It is a NA study. The enrollment target is 303 participants. The study started on 2019-01-28. Estimated completion is 2022-05-09.
What interventions are being tested in trial NCT03940300?
The interventions under investigation include: Fresh organic vegetables (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03940300?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.